 HEIDELBERG, Germany, Nov. 04, 2022 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD Affimed, or the Company, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release third quarter 2022 results and corporate update on Tuesday, November 15, 2022. The Company will host a conference call at 8:30 a.m. EST 14:30 CET. 